BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24558349)

  • 1. Pre-B cell receptor signaling induces immunoglobulin κ locus accessibility by functional redistribution of enhancer-mediated chromatin interactions.
    Stadhouders R; de Bruijn MJ; Rother MB; Yuvaraj S; Ribeiro de Almeida C; Kolovos P; Van Zelm MC; van Ijcken W; Grosveld F; Soler E; Hendriks RW
    PLoS Biol; 2014 Feb; 12(2):e1001791. PubMed ID: 24558349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A B-Cell-Specific Enhancer Orchestrates Nuclear Architecture to Generate a Diverse Antigen Receptor Repertoire.
    Barajas-Mora EM; Kleiman E; Xu J; Carrico NC; Lu H; Oltz EM; Murre C; Feeney AJ
    Mol Cell; 2019 Jan; 73(1):48-60.e5. PubMed ID: 30449725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.
    Lazorchak AS; Schlissel MS; Zhuang Y
    Mol Cell Biol; 2006 Feb; 26(3):810-21. PubMed ID: 16428437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Control of Long-Range Genomic Interactions at the Immunoglobulin κ Light-Chain Locus.
    Ribeiro de Almeida C; Hendriks RW; Stadhouders R
    Adv Immunol; 2015; 128():183-271. PubMed ID: 26477368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
    Shaffer AL; Peng A; Schlissel MS
    Immunity; 1997 Feb; 6(2):131-43. PubMed ID: 9047235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus.
    Sakamoto S; Wakae K; Anzai Y; Murai K; Tamaki N; Miyazaki M; Miyazaki K; Romanow WJ; Ikawa T; Kitamura D; Yanagihara I; Minato N; Murre C; Agata Y
    J Immunol; 2012 Jun; 188(11):5547-60. PubMed ID: 22544934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association.
    McDevit DC; Perkins L; Atchison ML; Nikolajczyk BS
    J Immunol; 2005 Mar; 174(5):2834-42. PubMed ID: 15728493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Enhancer Marks and Transcription Factor Binding Influence Vκ Gene Rearrangement in Pre-B Cells and Pro-B Cells.
    Kleiman E; Loguercio S; Feeney AJ
    Front Immunol; 2018; 9():2074. PubMed ID: 30271408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure.
    Nikolajczyk BS; Sardi SH; Tumang JR; Ganley-Leal LM
    Mol Immunol; 2007 Jul; 44(13):3407-15. PubMed ID: 17382392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in accessibility, nuclear positioning, recombination, and transcription at the Ig kappa locus.
    Fitzsimmons SP; Bernstein RM; Max EE; Skok JA; Shapiro MA
    J Immunol; 2007 Oct; 179(8):5264-73. PubMed ID: 17911612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAG2 involves the Igκ locus demethylation during B cell development.
    Wu C; Dong Y; Zhao X; Zhang P; Zheng M; Zhang H; Li S; Jin Y; Ma Y; Ren H; Ji Y
    Mol Immunol; 2017 Aug; 88():125-134. PubMed ID: 28641141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
    Liu Z; Garrard WT
    Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.
    Ta VB; de Haan AB; de Bruijn MJ; Dingjan GM; Hendriks RW
    Leukemia; 2011 Jan; 25(1):48-56. PubMed ID: 21030983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA-binding protein CTCF limits proximal Vκ recombination and restricts κ enhancer interactions to the immunoglobulin κ light chain locus.
    Ribeiro de Almeida C; Stadhouders R; de Bruijn MJ; Bergen IM; Thongjuea S; Lenhard B; van Ijcken W; Grosveld F; Galjart N; Soler E; Hendriks RW
    Immunity; 2011 Oct; 35(4):501-13. PubMed ID: 22035845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci.
    Inlay MA; Lin T; Gao HH; Xu Y
    J Exp Med; 2006 Jul; 203(7):1721-32. PubMed ID: 16785310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of activation and recombination of the murine Igkappa locus.
    Schlissel MS
    Immunol Rev; 2004 Aug; 200():215-23. PubMed ID: 15242407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling.
    Xu CR; Feeney AJ
    J Immunol; 2009 Feb; 182(3):1362-9. PubMed ID: 19155482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin opening is tightly linked to enhancer activation at the kappa light chain locus.
    Grange S; Boyes J
    Biochem Biophys Res Commun; 2007 Nov; 363(1):223-8. PubMed ID: 17868643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
    Zhou X; Xiang Y; Garrard WT
    J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.